Yue Liu

Yue Liu

Auto-generated profile, based on publicly available information

Yue Liu

State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YJyonghui jiang
yonghui jiang
HSHuangcong Shi
Huangcong Shi
YLYue Liu
Yue Liu
SZShigang Zhao
Shigang Zhao
HZHan Zhao
Han Zhao
Oxidative stress has been recognized as one of the causal mediators of female infertility by affecting the oocyte quality and early embryo development. Improving oxidative stress is essential for reproductive health. Melatonin, a self‐secreted antioxidant, has a wide range of effects by improving mitochondrial function and reducing the damage of reactive oxygen species (ROS). This minireview illustrates the applications of melatonin in reproduction from four aspects: physiological ovarian aging, vitrification freezing, in vitro maturation (IVM), and oxidative stress homeostasis imbalance associated with polycystic ovary syndrome (PCOS), emphasising the role of melatonin in improving the quality of oocytes in assisted reproduction and other adverse conditions.

2 November 2011 in Journal of Microencapsulation
Verified
Journal Article
Closed access
YLYue Liu
Yue Liu
DZDianrui Zhang
Dianrui Zhang
CDCunxian Duan
Cunxian Duan
LJLejiao Jia
Lejiao Jia
PXPengcheng Xie
Pengcheng Xie
QZQiang Zhang
Qiang Zhang
It is reported that the nanosuspension is one of the promising formulations for poorly water-soluble drugs. In order to enhance the in vitro and in vivo behaviours of DDB (bifendate), DDB-NSP (DDB nanosuspensions) have been produced by the precipitation-combined microfluidization method. The optimized DDB-NSP were transformed into dry powders by freeze-drying and then investigated by transmission electron microscopy, laser diffraction and X-ray diffraction (XRD) experiments. Next, the pharmacokinetics and biodistribution of DDB-NSP and DDB-Sol (DDB solution) were carried out. XRD experiments manifested that the crystalline state of DDB was preserved after the size reduction process. An accelerated dissolution velocity and increased saturation solubility could be shown for the DDB-NSP. Compared with DDB-Sol, DDB-NSP exhibited a markedly different pharmacokinetic property with a 17.18-fold increase in AUC0–∞. Meanwhile, the tissue distribution demonstrated that DDB-NSP were mainly uptaken by RES organs particularly by liver. These results supported the fact that nanosuspension, as a promising intravenous drug-delivery system for DDB, could be developed as an alternative to the conventional DDB preparations.

16 June 2026 in Phenomics
Verified
Journal Article
Closed access
PDF file
YLYue Liu
Yue Liu
SHShourui Hu
Shourui Hu
XLXiaofan Liang
Xiaofan Liang
JZJiaming Zhang
Jiaming Zhang
YQYiming Qin
Yiming Qin
YZYuqing Zhang
Yuqing Zhang